leisure time -WSS

leisure time

author：fashion 2025-08-11 16:24:56 - browse：625

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： What causes an itch? Researchers may have solved the mystery

explore

WSS

Grail faces three suits alleging harassment, retaliation

STAT letters to the editor on burnt

After sickle

Celiac disease study examines precisely how gluten triggers injury

Woman gored by Bison at Yellowstone

Argenx drug significantly slows progression of nerve disorder

knowledge

leisure time

Wikipedia

Medical records are filled with copy

STAT letters to the editor on burnt

Activists slam private health insurers over coverage restrictions

Leukemia patients are helped by Syndax's new type of therapy

Heart attack and stroke risk calculators need revising

SCOTUS to consider access to abortion pill mifepristone

Medicare details structure of new drug price negotiation program

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

The cancer drug shortage isn’t new — and neither are the solutions

Europe sees delivery challenges ahead on Alzheimer's therapies

focus

Care demand spikes challenge UnitedHealth’s provider arm

Pregnancy discrimination could be enabled by AI

Chemotherapy shortages won’t get better under Biden’s latest plan

Americans' trust in science, scientist continues decline: Report

What causes an itch? Researchers may have solved the mystery

SCOTUS to consider access to abortion pill mifepristone

explore

knowledge

focus

hotspot